Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Finasteride improves urinary function in men for 2 years.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Large prostates link to more hair loss.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Older patients sticking to their prostate medication saw lasting health benefits.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Ganoderma lucidum may help treat enlarged prostate in rats.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.